Statalist


[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

st: Analysis of pilot drug RCT with small samples and continuous DVs


From   "Jason Ferris" <[email protected]>
To   <[email protected]>
Subject   st: Analysis of pilot drug RCT with small samples and continuous DVs
Date   Mon, 3 Aug 2009 17:54:29 +1000

Stata 10 released Fisher's exact methods for small sample studies.
These methods are for non-linear (logistic, poisson) distributions and
apply to RxC based categorical models.  I would like to know if there
exists a more robust way of analysing small sample pilot studies (i.e.,
10 people in each treatment group: treatment and placebo) where the
outcome is continuous? That is, something similar to Stata's exact
statistics.
Cheers,
Jase

------------------------------------------
DISCLAIMER: This message (including any attachments) is intended solely for the addressee(s) named and may contain confidential or privileged information. 
If you are not the intended recipient, please delete it and notify the sender. 
Views expressed in this message are those of the individual sender,and are not necessarily the views of the Turning Point Alcohol and Drug Centre Inc (ABN: 17 302 055 629).  

<a href="http://www.turningpoint.org.au";>Turning Point Alcohol and Drug Centre Inc</a>

Although this message and any attachments have been scanned for viruses by 'Trend Micro InterScan' at the time of sending, 
you are advised to rescan on receipt.

The whole or parts of this email may be subject to copyright of Turning Point Alcohol and Drug Centre Inc (ABN: 17 302 055 629), and/or third parties. 
You can only re-transmit, distribute or use the material if you are authorised to do so.

Please consider the environment before printing this email or attachments.

*
*   For searches and help try:
*   http://www.stata.com/help.cgi?search
*   http://www.stata.com/support/statalist/faq
*   http://www.ats.ucla.edu/stat/stata/



© Copyright 1996–2024 StataCorp LLC   |   Terms of use   |   Privacy   |   Contact us   |   What's new   |   Site index